Literature DB >> 15120345

Tuberculosis in New York city: recent lessons and a look ahead.

William F Paolo1, Joshua D Nosanchuk.   

Abstract

In the late 1980s and early 1990s, after decades of decline, the incidence of tuberculosis began to rise in New York city, reaching a peak of 3811 cases by 1992. The epidemic took root in a setting of inadequate treatment regimens, homelessness, a diminished public-health system, and the onset of the HIV/AIDS epidemic. In addition, a subepidemic of drug-resistant tuberculosis occurred throughout New York city, most notably in a series of well documented nosocomial outbreaks. By 1994, using broadened initial treatment regimens, directly observed therapy, and improved US Centers for Disease Control and Prevention guidelines for hospital control and disease prevention, New York city began to effectively halt the progression of the epidemic. By 2002, tuberculosis rates in New York city reached an historic low of 1084. However, given the presence of a large reservoir of latently infected individuals in the city and an ongoing tuberculosis pandemic, New York city continues to face significant challenges from this persistent pathogen.

Entities:  

Mesh:

Year:  2004        PMID: 15120345     DOI: 10.1016/S1473-3099(04)01004-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  12 in total

1.  The impact of New York City's 1975 fiscal crisis on the tuberculosis, HIV, and homicide syndemic.

Authors:  Nicholas Freudenberg; Marianne Fahs; Sandro Galea; Andrew Greenberg
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

2.  A statistical model investigating the prevalence of tuberculosis in New York City using counting processes with two change-points.

Authors:  J A Achcar; E Z Martinez; A Ruffino-Netto; C D Paulino; P Soares
Journal:  Epidemiol Infect       Date:  2008-03-17       Impact factor: 2.451

Review 3.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Progress and new directions in genetics of tuberculosis: an NHLBI working group report.

Authors:  Issar Smith; Carl Nathan; Hannah H Peavy
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

5.  Tuberculosis in London: a decade and a half of no decline [corrected].

Authors:  Sarah R Anderson; Helen Maguire; Jacqui Carless
Journal:  Thorax       Date:  2006-11-13       Impact factor: 9.139

6.  Immune thrombocytopenic purpura as a presentation of childhood tuberculosis.

Authors:  Sriram Krishnamurthy; Sangeeta Yadav
Journal:  Indian J Pediatr       Date:  2007-09       Impact factor: 1.967

7.  X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB).

Authors:  Sudharsan Sridharan; Lei Wang; Alistair K Brown; Lynn G Dover; Laurent Kremer; Gurdyal S Besra; James C Sacchettini
Journal:  J Mol Biol       Date:  2006-11-07       Impact factor: 5.469

8.  Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients.

Authors:  Bella Mehta; Ekaterini Zapantis; Olga Petryna; Petros Efthimiou
Journal:  Arthritis       Date:  2015-07-29

9.  Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1-->3) arabinofuranosyltransferase.

Authors:  Helen L Birch; Luke J Alderwick; Apoorva Bhatt; Doris Rittmann; Karin Krumbach; Albel Singh; Yu Bai; Todd L Lowary; Lothar Eggeling; Gurdyal S Besra
Journal:  Mol Microbiol       Date:  2008-07-04       Impact factor: 3.501

10.  Tuberculosis presenting as immune thrombocytopenic purpura.

Authors:  Fahir Ozkalemkas; Ridvan Ali; Atilla Ozkan; Tulay Ozcelik; Vildan Ozkocaman; Esra Kunt-Uzaslan; Beril Bahadir-Erdogan; Halis Akalin
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-09-06       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.